16 Osteogenesis Imperfecta Clinical Trials in Detroit, MI (2026)

Q: How do I join a clinical trial in Detroit?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you.

Recruiting Osteogenesis Imperfecta Studies in Detroit

NCT05550298Recruiting

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

The participants are being asked to take part in this clinical trial, a type of research study, because the participants are scheduled to receive or have recently received a hematopoietic cell transpl...

Detroit, MI2,000 participantsArkansas Children's Hospital Research Institute

View Study Details

NCT06629272Recruiting

Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing

The proposed study focuses on testing a novel adapted evidence-based multilevel intervention, Deprescribing Thyroid Hormone In Older Adults (D-THIO), to support thyroid hormone deprescribing (dose de-...

Detroit, MINA900 participantsUniversity of Michigan

View Study Details

NCT06501040Recruiting

Increasing Knowledge and Interest in Cancer Clinical Trials

This trial investigates how well a video-based clinical trial education session works in increasing knowledge and interest in cancer clinical trials among individuals in the metropolitan Detroit regio...

Detroit, MINA384 participantsHayley Thompson

View Study Details

NCT05005975Recruiting

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

To evaluate the long-term safety and tolerability of oral dersimelagon....

Detroit, MIPHASE3301 participantsMitsubishi Tanabe Pharma America Inc.

View Study Details

NCT06292780Recruiting

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

This study is researching an experimental drug called linvoseltamab ("study drug"). This study is focused on patients who have AL amyloidosis that has returned or have failed other therapies and need...

Detroit, MIPHASE1220 participantsRegeneron Pharmaceuticals

View Study Details

NCT07137598Recruiting

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate re...

Detroit, MIPHASE2160 participantsHoffmann-La Roche

View Study Details

NCT07087054Recruiting

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

A Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of paltusotine in adults with ca...

Detroit, MIPHASE3141 participantsCrinetics Pharmaceuticals Inc.

View Study Details

NCT05890729Recruiting

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

A phase 1b/2 study of XTMAB-16 in patients with pulmonary sarcoidosis...

Detroit, MIPHASE194 participantsXentria, Inc.

View Study Details

NCT07081646Recruiting

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

Open-label Phase 1b/2 study with primary objective of this study is to evaluate the safety, tolerability and efficacy of AZD0120 in participants with light chain (AL) amyloidosis....

Detroit, MIPHASE191 participantsAlexion Pharmaceuticals, Inc.

View Study Details

NCT06113211Recruiting

Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures

An open reduction and internal fixation is a painful procedure requiring intensive postoperative pain management. Traditionally, opioid analgesia has been the gold standard for postoperative pain cont...

Detroit, MIPHASE475 participantsHenry Ford Health System

View Study Details

NCT04838041Recruiting

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

This is a single arm phase II study that will enroll a minimum of 47 subjects with a maximum of 51. All patients will have a confirmed diagnosis of chronic phase chronic myeloid Leukemia and must have...

Detroit, MIPHASE251 participantsMedical College of Wisconsin

View Study Details

NCT03850418Recruiting

Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

Previous studies provide a rationale for administration of AZA after allo SCT for decreasing chimerism. The investigators hypothesize that azacitidine can be well tolerated after SCT and help decrease...

Detroit, MIPHASE243 participantsHenry Ford Health System

View Study Details

NCT05738005Recruiting

Dietary Reporting In The Amyloidoses

The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis. The main question it aims to answer is: Is it feasible to use a low-cost nutrition-based ...

Detroit, MINA40 participantsBarbara Ann Karmanos Cancer Institute

View Study Details

NCT05006079Recruiting

Opioid/Benzodiazepine Polydrug Abuse: Aim 3

In this study, the investigators will measure affective, neurocognitive and behavioral outcomes related to chronic use of opioids and benzodiazepines (screening phase), and in response to the administ...

Detroit, MIPHASE224 participantsWayne State University

View Study Details

NCT06420167Recruiting

DapagliFLOzin in Renal AL Amyloidosis (FLORAL)

The goal of this clinical trial is to learn if an oral drug called dapagliflozin is safe and can reduce high protein levels in the urine of patients with renal amyloid light-chain (AL) amyloidosis usi...

Detroit, MIPHASE220 participantsBarbara Ann Karmanos Cancer Institute

View Study Details

NCT06065371Recruiting

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

This is a Phase I study to evaluate the safety and tolerability of sacituzumab govitecan in combination with capecitabine for advanced gastrointestinal cancers after progression on standard therapy, a...

Detroit, MIPHASE120 participantsHenry Ford Health System

View Study Details

About Osteogenesis Imperfecta Clinical Trials in Detroit

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 16 osteogenesis imperfecta clinical trials recruiting participants in Detroit, MI. These studies are seeking a combined 4,564 participants. Research is being sponsored by Arkansas Children's Hospital Research Institute, University of Michigan, Hayley Thompson and 10 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Detroit — FAQ

Are there osteogenesis imperfecta clinical trials in Detroit?

Yes, there are 16 osteogenesis imperfecta clinical trials currently recruiting in Detroit, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Detroit?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Detroit research site will contact you about next steps.

Are clinical trials in Detroit free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Detroit studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 16 active trials in Detroit are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated September 2, 2026 from ClinicalTrials.gov